US HB9142 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on July 25 2024 - 25% progression
Action: 2024-07-25 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 25 2024 - 25% progression
Action: 2024-07-25 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
Title
Responsibility in Drug Advertising Act of 2024
Sponsors
Rep. Rosa DeLauro [D-CT] |
History
Date | Chamber | Action |
---|---|---|
2024-07-25 | House | Referred to the House Committee on Energy and Commerce. |
2024-07-25 | House | Introduced in House |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/9142/all-info |
Text | https://www.congress.gov/118/bills/hr9142/BILLS-118hr9142ih.pdf |